Additionally, the co-occurrence of FLT3-ITD with other mutations such as the mutations of nucleophosmin (NPM1) and DNA methyltransferase 3A (DNMT3A) are further reported [6,7], indicative of their importance as excellent genetic biomarkers for early and relapse diagnosis of AML in patients. Here, FLT3 is linked to acute myeloid leukemia.